Table 1.

Demographic and Clinical Characteristics of the Study Participants

VariablesPatients (n = 128)Caregivers (n = 106)P-Value
n (%)n (%)
Age group.009
 20s7 (5.5)1 (1.0)
 30s16 (12.6)10 (9.6)
 40s41 (32.3)18 (17.3)
 50s35 (27.6)33 (31.7)
 60s18 (14.2)28 (26.9)
 70s9 (7.1)14 (13.5)
 80s1 (0.8)0 (0.0)
 Not stated12
Sex<.001
 Male76 (60.3)36 (34.0)
 Female50 (39.7)70 (66.0)
 Not stated20
Age group of the care recipients
 20sN/Aa14 (13.2)
 30sN/A7 (6.6)
 40sN/A19 (17.9)
 50sN/A17 (16.0)
 60sN/A27 (25.5)
 70sN/A18 (17.0)
 80sN/A4 (3.8)
Sex of the care recipients
 MaleN/A65 (61.3)
 FemaleN/A41 (38.7)
Relationship with the patient
 Spouse/partnerN/A69 (65.1)
 ParentN/A19 (17.9)
 ChildN/A12 (11.3)
 SiblingN/A5 (4.7)
 Other (cousin or other peer)N/A1 (0.9)
Primary caregiver and surrogate decision-maker regarding the patients’ medical treatment and care
 YesN/A89 (93.7)
 NoN/A6 (6.3)
 Not statedN/A11
Duration since brain tumor diagnosis.487
 Less than 6 months13 (10.2)10 (9.4)
 6 months to less than 1 year10 (7.8)16 (15.1)
 1 year to less than 2 years19 (14.8)20 (18.9)
 2 years to less than 5 years40 (31.3)29 (27.4)
 5 years to less than 10 years25 (19.5)17 (16.0)
 10 years or more21 (16.4)14 (13.2)
Treatment facility for brain tumors.118
 University hospital64 (50.4)47 (44.3)
 Cancer center56 (44.1)45 (42.5)
 Other hospitals7 (5.5)14 (13.2)
Patient’s surgical history of brain tumors.726
 Yes122 (95.3)99 (93.4)
 No6 (4.7)7 (6.6)
Types of primary malignant brain tumors.117
 Glioblastoma43 (33.6)48 (45.3)
 Glioma grade 334 (26.6)27 (25.5)
 Glioma grade 236 (28.1)11 (10.4)
 Primary central nervous system lymphoma5 (3.9)5 (4.7)
 Other malignant brain tumors10 (7.8)15 (14.2)
Patient’s KPSb<.001
 ≥70113 (88.3)61 (57.5)
 <7015 (11.7)45 (42.5)
Distress and Impact Thermometer.009
 Positive29 (23.0)41 (39.8)
 Negative97 (77.0)62 (60.2)
VariablesPatients (n = 128)Caregivers (n = 106)P-Value
n (%)n (%)
Age group.009
 20s7 (5.5)1 (1.0)
 30s16 (12.6)10 (9.6)
 40s41 (32.3)18 (17.3)
 50s35 (27.6)33 (31.7)
 60s18 (14.2)28 (26.9)
 70s9 (7.1)14 (13.5)
 80s1 (0.8)0 (0.0)
 Not stated12
Sex<.001
 Male76 (60.3)36 (34.0)
 Female50 (39.7)70 (66.0)
 Not stated20
Age group of the care recipients
 20sN/Aa14 (13.2)
 30sN/A7 (6.6)
 40sN/A19 (17.9)
 50sN/A17 (16.0)
 60sN/A27 (25.5)
 70sN/A18 (17.0)
 80sN/A4 (3.8)
Sex of the care recipients
 MaleN/A65 (61.3)
 FemaleN/A41 (38.7)
Relationship with the patient
 Spouse/partnerN/A69 (65.1)
 ParentN/A19 (17.9)
 ChildN/A12 (11.3)
 SiblingN/A5 (4.7)
 Other (cousin or other peer)N/A1 (0.9)
Primary caregiver and surrogate decision-maker regarding the patients’ medical treatment and care
 YesN/A89 (93.7)
 NoN/A6 (6.3)
 Not statedN/A11
Duration since brain tumor diagnosis.487
 Less than 6 months13 (10.2)10 (9.4)
 6 months to less than 1 year10 (7.8)16 (15.1)
 1 year to less than 2 years19 (14.8)20 (18.9)
 2 years to less than 5 years40 (31.3)29 (27.4)
 5 years to less than 10 years25 (19.5)17 (16.0)
 10 years or more21 (16.4)14 (13.2)
Treatment facility for brain tumors.118
 University hospital64 (50.4)47 (44.3)
 Cancer center56 (44.1)45 (42.5)
 Other hospitals7 (5.5)14 (13.2)
Patient’s surgical history of brain tumors.726
 Yes122 (95.3)99 (93.4)
 No6 (4.7)7 (6.6)
Types of primary malignant brain tumors.117
 Glioblastoma43 (33.6)48 (45.3)
 Glioma grade 334 (26.6)27 (25.5)
 Glioma grade 236 (28.1)11 (10.4)
 Primary central nervous system lymphoma5 (3.9)5 (4.7)
 Other malignant brain tumors10 (7.8)15 (14.2)
Patient’s KPSb<.001
 ≥70113 (88.3)61 (57.5)
 <7015 (11.7)45 (42.5)
Distress and Impact Thermometer.009
 Positive29 (23.0)41 (39.8)
 Negative97 (77.0)62 (60.2)

a“N/A” for missing data.

bPatient’s KPS, as reported by caregivers, is based on the caregiver’s observations of the patient’s activities of daily living.

Table 1.

Demographic and Clinical Characteristics of the Study Participants

VariablesPatients (n = 128)Caregivers (n = 106)P-Value
n (%)n (%)
Age group.009
 20s7 (5.5)1 (1.0)
 30s16 (12.6)10 (9.6)
 40s41 (32.3)18 (17.3)
 50s35 (27.6)33 (31.7)
 60s18 (14.2)28 (26.9)
 70s9 (7.1)14 (13.5)
 80s1 (0.8)0 (0.0)
 Not stated12
Sex<.001
 Male76 (60.3)36 (34.0)
 Female50 (39.7)70 (66.0)
 Not stated20
Age group of the care recipients
 20sN/Aa14 (13.2)
 30sN/A7 (6.6)
 40sN/A19 (17.9)
 50sN/A17 (16.0)
 60sN/A27 (25.5)
 70sN/A18 (17.0)
 80sN/A4 (3.8)
Sex of the care recipients
 MaleN/A65 (61.3)
 FemaleN/A41 (38.7)
Relationship with the patient
 Spouse/partnerN/A69 (65.1)
 ParentN/A19 (17.9)
 ChildN/A12 (11.3)
 SiblingN/A5 (4.7)
 Other (cousin or other peer)N/A1 (0.9)
Primary caregiver and surrogate decision-maker regarding the patients’ medical treatment and care
 YesN/A89 (93.7)
 NoN/A6 (6.3)
 Not statedN/A11
Duration since brain tumor diagnosis.487
 Less than 6 months13 (10.2)10 (9.4)
 6 months to less than 1 year10 (7.8)16 (15.1)
 1 year to less than 2 years19 (14.8)20 (18.9)
 2 years to less than 5 years40 (31.3)29 (27.4)
 5 years to less than 10 years25 (19.5)17 (16.0)
 10 years or more21 (16.4)14 (13.2)
Treatment facility for brain tumors.118
 University hospital64 (50.4)47 (44.3)
 Cancer center56 (44.1)45 (42.5)
 Other hospitals7 (5.5)14 (13.2)
Patient’s surgical history of brain tumors.726
 Yes122 (95.3)99 (93.4)
 No6 (4.7)7 (6.6)
Types of primary malignant brain tumors.117
 Glioblastoma43 (33.6)48 (45.3)
 Glioma grade 334 (26.6)27 (25.5)
 Glioma grade 236 (28.1)11 (10.4)
 Primary central nervous system lymphoma5 (3.9)5 (4.7)
 Other malignant brain tumors10 (7.8)15 (14.2)
Patient’s KPSb<.001
 ≥70113 (88.3)61 (57.5)
 <7015 (11.7)45 (42.5)
Distress and Impact Thermometer.009
 Positive29 (23.0)41 (39.8)
 Negative97 (77.0)62 (60.2)
VariablesPatients (n = 128)Caregivers (n = 106)P-Value
n (%)n (%)
Age group.009
 20s7 (5.5)1 (1.0)
 30s16 (12.6)10 (9.6)
 40s41 (32.3)18 (17.3)
 50s35 (27.6)33 (31.7)
 60s18 (14.2)28 (26.9)
 70s9 (7.1)14 (13.5)
 80s1 (0.8)0 (0.0)
 Not stated12
Sex<.001
 Male76 (60.3)36 (34.0)
 Female50 (39.7)70 (66.0)
 Not stated20
Age group of the care recipients
 20sN/Aa14 (13.2)
 30sN/A7 (6.6)
 40sN/A19 (17.9)
 50sN/A17 (16.0)
 60sN/A27 (25.5)
 70sN/A18 (17.0)
 80sN/A4 (3.8)
Sex of the care recipients
 MaleN/A65 (61.3)
 FemaleN/A41 (38.7)
Relationship with the patient
 Spouse/partnerN/A69 (65.1)
 ParentN/A19 (17.9)
 ChildN/A12 (11.3)
 SiblingN/A5 (4.7)
 Other (cousin or other peer)N/A1 (0.9)
Primary caregiver and surrogate decision-maker regarding the patients’ medical treatment and care
 YesN/A89 (93.7)
 NoN/A6 (6.3)
 Not statedN/A11
Duration since brain tumor diagnosis.487
 Less than 6 months13 (10.2)10 (9.4)
 6 months to less than 1 year10 (7.8)16 (15.1)
 1 year to less than 2 years19 (14.8)20 (18.9)
 2 years to less than 5 years40 (31.3)29 (27.4)
 5 years to less than 10 years25 (19.5)17 (16.0)
 10 years or more21 (16.4)14 (13.2)
Treatment facility for brain tumors.118
 University hospital64 (50.4)47 (44.3)
 Cancer center56 (44.1)45 (42.5)
 Other hospitals7 (5.5)14 (13.2)
Patient’s surgical history of brain tumors.726
 Yes122 (95.3)99 (93.4)
 No6 (4.7)7 (6.6)
Types of primary malignant brain tumors.117
 Glioblastoma43 (33.6)48 (45.3)
 Glioma grade 334 (26.6)27 (25.5)
 Glioma grade 236 (28.1)11 (10.4)
 Primary central nervous system lymphoma5 (3.9)5 (4.7)
 Other malignant brain tumors10 (7.8)15 (14.2)
Patient’s KPSb<.001
 ≥70113 (88.3)61 (57.5)
 <7015 (11.7)45 (42.5)
Distress and Impact Thermometer.009
 Positive29 (23.0)41 (39.8)
 Negative97 (77.0)62 (60.2)

a“N/A” for missing data.

bPatient’s KPS, as reported by caregivers, is based on the caregiver’s observations of the patient’s activities of daily living.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close